Download PDF - 230 Downloads
Article DOI: 10-59708-ajlhts-v4i1-2510
Abstract
Anaemia during pregnancy remains a significant public health concern, particularly in sub-Saharan Africa (SSA), where it is a leading cause of maternal and perinatal morbidity and mortality.
Anaemia affects nearly half of all pregnant women in SSA, with iron deficiency, malaria, and HIV among the primary contributors. The condition exacerbates maternal risks, including postpartum
haemorrhage and preeclampsia, while increasing the likelihood of adverse fetal outcomes such as preterm birth and low birth weight. Effective management requires a multifaceted approach,
including iron and folate supplementation, malaria prophylaxis, and dietary fortification programmes . Novel strategies, such as improved formulations of iron supplements and genetic screening for haemoglobinopathies, are showing promise in addressing this complex condition. Despite advances, significant knowledge gaps persist, particularly regarding long-term outcomes and barriers to care. Addressing these gaps through further research and tailored policies is vital to improving maternal health outcomes in SSA and achieving global health targets.